01302.HK
LifeTech Scientific Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 1.39
+2.59%Year over year
Reported trailing growth
- Revenue
- +6.1%
- EBITDA
- -47.4%
- EBIT
- -75.4%
- EPS
- -77.5%
- Free cash flow
- +187.5%
- Operating cash flow
- -16.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.7%
- EBITDA
- -13.2%
- EBIT
- -21.1%
- Net income
- -23.1%
- EPS
- -24.6%
- Free cash flow
- +111.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026